• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua

tetano

Editor, Senior Moderator
Nat Commun


. 2022 Mar 4;13(1):1190.
doi: 10.1038/s41467-022-28858-9.
Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua


Steph Wraith[SUP] 1 [/SUP], Angel Balmaseda[SUP] 2 3 [/SUP], Fausto Andres Bustos Carrillo[SUP] 4 [/SUP], Guillermina Kuan[SUP] 2 5 [/SUP], John Huddleston[SUP] 6 [/SUP], John Kubale[SUP] 1 [/SUP], Roger Lopez[SUP] 2 3 [/SUP], Sergio Ojeda[SUP] 2 [/SUP], Amy Schiller[SUP] 1 [/SUP], Brenda Lopez[SUP] 2 [/SUP], Nery Sanchez[SUP] 2 [/SUP], Richard Webby[SUP] 7 [/SUP], Martha I Nelson[SUP] 8 [/SUP], Eva Harris[SUP] 4 [/SUP], Aubree Gordon[SUP] 9 [/SUP]



Affiliations
Free article

Abstract

The period of protection from repeat infection following symptomatic influenza is not well established due to limited availability of longitudinal data. Using data from a pediatric cohort in Managua, Nicaragua, we examine the effects of natural influenza virus infection on subsequent infection with the same influenza virus subtype/lineage across multiple seasons, totaling 2,170 RT-PCR-confirmed symptomatic influenza infections. Logistic regression models assessed whether infection in the prior influenza season protected against homologous reinfection. We sequenced viruses from 2011-2019 identifying dominant clades and measuring antigenic distances between hemagglutinin clades. We observe homotypic protection from repeat infection in children infected with influenza A/H1N1pdm (OR 0.12, CI 0.02-0.88), A/H3N2 (OR 0.41, CI 0.24-0.73), and B/Victoria (OR 0.00, CI 0.00-0.14), but not with B/Yamagata viruses (OR 0.60, CI 0.09-2.10). Overall, protection wanes as time or antigenic distance increases. Individuals infected with one subtype or lineage of influenza virus have significantly lower odds of homologous reinfection for the following one to two years; after two years this protection wanes. This protection is demonstrated across multiple seasons, subtypes, and lineages among children.
 
Back
Top Bottom